| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.avonlifesciences.com | |
| Market Cap | 7.15 Cr. | |
| Enterprise Value(EV) | 146.71 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -2.28 | Trailing Twelve Months Ending 2023-09 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
| Industry PE | 38.52 | Trailing Twelve Months Ending 2023-09 |
| Book Value / Share | -54.74 | Trailing Twelve Months Ending 2023-09 |
| Price to Book Value | -0.05 | Calculated using Price: 3.00 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.38 Cr. | 23,825,000 Shares |
| FaceValue | 10 | |
| About Kobo Biotech Ltd. | ||
| AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying into the highly technology-intensive area of Diketene and its derivatives. | ||
| 1 Day |
|
+0.33% |
| 1 Week |
|
-4.15% |
| 1 Month |
|
+17.65% |
| 3 Month |
|
+5.26% |
| 6 Month |
|
+25.52% |
| 1 Year |
|
-31.03% |
| 2 Year |
|
-50.25% |
| 5 Year |
|
-45.45% |
| 10 Year |
|
-69.39% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -103.90 | -233.98 | ||||||||
| Return on Capital Employed (%) | -8.67 | -1.32 | -2.78 | -5.12 | -5.74 | -3.93 | -5.31 | -17.59 | -36.84 | |
| Return on Assets (%) | -11.40 | -6.43 | -7.50 | -9.60 | -10.08 | -8.83 | -8.24 | -9.83 | -7.19 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 14 | 6 | -19 | -43 | -67 | -88 | -107 | -122 | -128 | -130 | |
| Non Curr. Liab. | 74 | 74 | 64 | 47 | 40 | 40 | 39 | 38 | 37 | 37 | |
| Curr. Liab. | 164 | 180 | 207 | 242 | 266 | 284 | 299 | 163 | 166 | 166 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 252 | 260 | 252 | 246 | 239 | 236 | 231 | 79 | 75 | 73 | |
| Non Curr. Assets | 110 | 102 | 95 | 89 | 83 | 77 | 71 | 42 | 38 | 36 | |
| Curr. Assets | 142 | 158 | 157 | 157 | 157 | 159 | 159 | 38 | 38 | 38 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 252 | 260 | 252 | 246 | 239 | 236 | 231 | 79 | 75 | 73 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
| Net Sales | 29 | 33 | |||||||||
| Other Income | 1 | 1 | 6 | 0 | 1 | 2 | 0 | 133 | 0 | 0 | |
| Total Income | 30 | 34 | 6 | 0 | 1 | 2 | 0 | 133 | 0 | 0 | |
| Total Expenditure | -39 | -29 | -4 | -3 | -3 | -3 | -3 | -144 | -2 | -1 | |
| PBIDT | -9 | 5 | 2 | -3 | -2 | -1 | -3 | -10 | -1 | -1 | |
| Interest | -16 | -14 | -14 | -15 | -14 | -14 | -11 | 0 | |||
| Depreciation | -8 | -7 | -7 | -6 | -6 | -6 | -6 | -5 | -4 | -4 | |
| Taxation | |||||||||||
| Exceptional Items | 3 | -2 | |||||||||
| PAT | -30 | -16 | -19 | -24 | -24 | -21 | -19 | -15 | -6 | -5 | |
| Adjusted EPS | -13 | -7 | -8 | -10 | -10 | -9 | -8 | -6 | -2 | -2 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 11 | 19 | 6 | 32 | 31 | 21 | 14 | 3 | 94 | 1 | |
| Cash Fr. Inv. | -5 | 25 | |||||||||
| Cash Fr. Finan. | -7 | -21 | -5 | -33 | -31 | -21 | -14 | -1 | -120 | -1 | |
| Net Change | -1 | -1 | 0 | 0 | 1 | -1 | |||||
| Cash & Cash Eqvt | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
|
Fri, 10 Nov 2023
Related Party Transaction For The Hald Year Ended 30-09-2023 Related Party Transaction for the Half year ended 30-09-2023 |
|
Fri, 10 Nov 2023
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2023 The Board of Director of the company at their meeting held today i.e. 10th November 2023 inter alia approved the unaudited financials results for the quarter and half year ended 30th September 2023 |
|
Fri, 03 Nov 2023
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday 10Th November 2023. Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the unaudited financial result for the 2nd Quarter and half year ended 30th September 2023. |
| Fri, 08 Dec 2023 |
High Delivery Percentage
|
High Increase in 1 Month
|
High Increase in 6 Months
|
| Thu, 07 Dec 2023 |
|
High Delivery Percentage
|
Closing Below Previous Low
|
Equities
M.F.
Sectors
StockEdge Social